Intelligent Bio Solutions Inc. (INBS) — Cash Flow-to-Debt Ratio
Intelligent Bio Solutions Inc. (INBS) has a Cash Flow-to-Debt Ratio of -0.43x as of September 2025, meaning its operating cash flow of $-2.85 Million could theoretically repay 0% of its total liabilities ($6.61 Million) in one year. See how much free cash does Intelligent Bio Solutions Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Intelligent Bio Solutions Inc. Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Intelligent Bio Solutions Inc. across 9 annual periods. Also explore Intelligent Bio Solutions Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Intelligent Bio Solutions Inc. (2017–2025)
Year-by-year debt coverage analysis for Intelligent Bio Solutions Inc.. For market capitalisation and broader financial context, see Intelligent Bio Solutions Inc. stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.78x | $-9.68 Million | $5.44 Million | ▼ -4.1% |
| 2024 | -1.71x | $-9.57 Million | $5.60 Million | ▼ -54.6% |
| 2023 | -1.11x | $-7.38 Million | $6.67 Million | ▼ -91.3% |
| 2022 | -0.58x | $-3.36 Million | $5.81 Million | ▲ +64.9% |
| 2021 | -1.65x | $-11.30 Million | $6.85 Million | ▼ -2442.5% |
| 2020 | -0.06x | $-498.62K | $7.69 Million | ▲ +92.7% |
| 2019 | -0.88x | $-5.58 Million | $6.31 Million | ▲ +8.7% |
| 2018 | -0.97x | $-5.38 Million | $5.56 Million | ▼ -2513.0% |
| 2017 | -0.04x | $-243.89K | $6.58 Million | — |